Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lukas Harries"'
Autor:
Richard S P Huang, Lukas Harries, Brennan Decker, Matthew C Hiemenz, Karthikeyan Murugesan, James Creeden, Khaled Tolba, Laura P Stabile, Shakti H Ramkissoon, Timothy F Burns, Jeffrey S Ross
Publikováno v:
The Oncologist. 27:839-848
Background In patients with non-small cell lung cancer (NSCLC), 10%-40% will eventually develop brain metastases. We present the clinicopathologic, genomic, and biomarker landscape of a large cohort of NSCLC brain metastases (NSCLC-BM) samples. Mater
Autor:
Richard S P Huang, Julie Y Tse, Lukas Harries, Ryon P Graf, Douglas I Lin, Karthikeyan Murugesan, Matthew C Hiemenz, Vamsi Parimi, Tyler Janovitz, Brennan Decker, Eric Severson, Mia A Levy, Shakti H Ramkissoon, Julia A Elvin, Jeffrey S Ross, Erik A Williams
Publikováno v:
The Oncologist. 27:655-662
Background In the current study, we examined the real-world prevalence of highly pigmented advanced melanomas (HPMel) and the clinicopathologic, genomic, and ICPI biomarker signatures of this class of tumors. Materials and Methods Our case archive of
Autor:
Matthew C. Hiemenz, Jaspreet Kaur, Zheng Kuang, Richard S. P. Huang, Lukas Harries, Dana Metzger, Kelsie Schiavone, Sherri Z. Millis, Douglas I. Lin, Mirna Lechpammer, Brennan Decker, Douglas A. Mata, Abhinav Reddy, Matthew Parke, Eun Y. Lee, Xiaoyan Cui, O. Hans Iwenofu, Darya Buehler, Les Henderson, Erin M. Baldwin, Sosipatros A. Boikos, Shakti H. Ramkissoon, Steven C. Smith
Publikováno v:
Genes, Chromosomes and Cancer.
Autor:
Matthew C Hiemenz, Ryon P Graf, Kelsie Schiavone, Lukas Harries, Geoffrey R Oxnard, Jeffrey S Ross, Richard S P Huang
Publikováno v:
The oncologist.
Challenges with sequencing tissue samples from patients with prostate cancer have been reported in clinical trials. To assess the success rate of comprehensive genomic profiling (CGP) for prostate cancer patients, we analyzed a real-world cohort who
Autor:
Douglas A. Mata, Lukas Harries, Erik A. Williams, Matthew C. Hiemenz, Brennan Decker, Julie Y. Tse, Tyler Janovitz, Donna C. Ferguson, Iain A. Speece, Matthew L. Margolis, Benjamin Mathews, Kyle Fedorchak, J. Keith Killian, Jinpeng Xiao, Khaled A. Tolba, Shakti Ramkissoon, Jo-Anne Vergilio, Julia A. Elvin, Geoffrey R. Oxnard, Jeffrey S. Ross, Richard S. P. Huang
Publikováno v:
Archives of pathologylaboratory medicine.
Context.— Multiple procedural techniques can be used to obtain tissue to create a formalin-fixed, paraffin-embedded specimen for comprehensive genomic profiling (CGP) in lung cancer. The literature is mixed on whether the procedure affects CGP succ
Autor:
Douglas I. Lin, Jinpeng Xiao, James Creeden, Amanda Hemmerich, James Haberberger, Shakti H. Ramkissoon, Karthikeyan Murugesan, Deborah L. McEwan, Matthew Hiemenz, N. Lynn Ferguson, Julia A. Elvin, Lukas Harries, Daniel L. Duncan, Richard S.P. Huang, Oliver Holmes, Jeffrey M. Venstrom, Jeffrey S. Ross, Claire Edgerly, Eric Allan Severson
Publikováno v:
Oncologist
Introduction Pembrolizumab was approved with an accompanying companion diagnostic (CDx) assay (PD-L1 DAKO 22C3) for urothelial carcinoma (UC). In this study, we further characterize the clinicopathologic and genomic features of UC that are programmed
Autor:
Lukas Harries, Zachary J. Donhauser
Publikováno v:
The FASEB Journal. 33